Heart failure and erectile dysfunction frequently occur together because sexual function depends on adequate circulation, endothelial signaling, physical capacity, and psychological confidence. Heart failure can disrupt each of these systems. Erectile symptoms may also be overlooked when appointments focus on breathing, fluid retention, blood pressure, and medication changes. Yet sexual health is part of cardiovascular quality of life, and a new or worsening change in erections deserves a careful, medically supervised evaluation rather than an assumption that it is an unavoidable consequence of aging.
Heart Failure and Erectile Dysfunction: What the Evidence Shows
Heart failure does not mean that the heart has stopped. It means the heart cannot fill or pump efficiently enough to meet the body's needs without compensatory changes. Some people have heart failure with reduced ejection fraction, while others have preserved ejection fraction but impaired filling and elevated pressures. Both forms can produce fatigue, shortness of breath, reduced exercise capacity, and vascular dysfunction.
Sexual problems are common across this population. A 2022 systematic review by da Silva and colleagues included 15 studies and 6,244 participants with heart failure. The authors found disruption across multiple phases of sexual response, including desire, arousal, erection, orgasm, and satisfaction. The review also emphasized that the evidence was heterogeneous: studies used different questionnaires, enrolled patients with different disease severity, and did not always separate erectile function from broader sexual well-being.[1]
A 2023 review in Current Heart Failure Reports similarly concluded that erectile dysfunction is highly prevalent in heart failure and has multiple interacting causes.[2] Smaller clinical cohorts help illustrate the burden but should not be treated as population-wide estimates. In one 2022 pilot study of 98 men attending a heart-failure clinic, 76.5% met questionnaire criteria for some degree of erectile dysfunction.[3] Earlier cohorts have reported similarly high rates, although prevalence changes with age, diabetes, coronary disease, heart-failure severity, and the definition used.
The practical conclusion is not that every man with heart failure will develop ED. It is that the association is strong enough for clinicians and patients to discuss sexual function routinely, especially when symptoms are new, progressive, or affecting medication adherence and relationships.
Why Heart Failure Can Affect Erections
An erection requires coordinated arterial inflow, relaxation of smooth muscle in penile tissue, nitric oxide signaling, temporary restriction of venous outflow, intact nerve function, and sufficient sexual stimulation. Heart failure can interfere at several points.
First, endothelial dysfunction is common. The endothelium is the inner cellular lining of blood vessels and helps regulate dilation through nitric oxide. Hypertension, diabetes, atherosclerosis, smoking, inflammation, and oxidative stress can reduce nitric oxide availability. These conditions are major contributors to heart failure and also impair the vascular response required for an erection.
Second, reduced cardiac output and limited exercise capacity can make sexual activity physically difficult. Breathlessness, rapid fatigue, swelling, or chest discomfort may interrupt arousal or make a person avoid intimacy. Neurohormonal activation may also contribute: chronic stimulation of sympathetic and renin-angiotensin-aldosterone pathways helps sustain circulation in heart failure but can increase vasoconstriction and vascular stress over time.
Third, heart failure often coexists with conditions that independently increase ED risk, including diabetes, chronic kidney disease, obesity, sleep apnea, depression, and coronary artery disease. It is therefore rarely possible to assign erectile symptoms to a single mechanism.
Genetic epidemiology provides an additional, though indirect, line of evidence. In a 2023 Mendelian randomization analysis, Li and colleagues found that genetic liability to heart failure was associated with greater odds of erectile dysfunction. The reported odds ratio was 1.36.[4] Mendelian randomization can reduce some forms of confounding, but it does not prove that one individual's heart failure directly caused his ED, nor does it replace clinical trial evidence.
Medications, Symptoms, and Other Contributors
Men sometimes stop cardiovascular medication because they believe it is causing ED. That can be dangerous. Abruptly discontinuing a beta blocker, diuretic, renin-angiotensin system drug, or another prescribed therapy may destabilize heart failure. The correct response is a medication review with the prescribing clinician.
Some older beta blockers and thiazide-type diuretics have been associated with erectile symptoms in observational studies, but the relationship is not uniform. The underlying vascular disease, expectations about side effects, dose, concurrent drugs, and depression can all influence reported function. Some contemporary heart-failure therapies may be neutral or potentially favorable through improved symptoms and vascular health, although sexual outcomes are not the primary endpoint in most trials.
Other medicines deserve attention. Nitrates, including nitroglycerin and isosorbide products, must not be combined with phosphodiesterase type 5 inhibitors such as sildenafil, tadalafil, or vardenafil because the combination can produce a dangerous fall in blood pressure. Recreational nitrites, sometimes called "poppers," carry the same concern. Alpha blockers and multiple blood-pressure-lowering medicines may also require cautious timing and dose selection.
Psychological factors are equally real. Fear that sexual activity will trigger a cardiac event, reduced body confidence, depression, relationship strain, and performance anxiety can reduce desire and interfere with arousal. These effects can persist even after heart-failure symptoms improve. A clinical assessment should therefore cover mood, relationship context, sleep, alcohol, medication use, and physical symptoms rather than focusing only on penile blood flow.
Evaluation and Treatment Safety
New erectile dysfunction in a person with known heart failure should prompt a structured review. Clinicians may assess symptom stability, functional capacity, blood pressure, cardiovascular risk, medication interactions, glucose control, kidney function, anemia, testosterone when clinically indicated, and signs of depression or sleep apnea. Sudden ED accompanied by chest pain, fainting, rapidly worsening breathlessness, or new exercise intolerance requires urgent medical attention.
Whether sexual activity is safe depends more on cardiovascular stability and exercise tolerance than on the heart-failure label alone. Stable patients who can perform moderate physical activity without chest pain, marked breathlessness, dangerous arrhythmia, or a major blood-pressure response may often resume sexual activity after individualized review. People with decompensated heart failure, severe symptoms at rest, unstable angina, or uncontrolled arrhythmias generally need stabilization before sexual activity or ED drug treatment is considered.
PDE5 inhibitors can be effective for appropriate cardiac patients, but prescribing requires explicit screening for nitrates, low blood pressure, recent cardiovascular events, and other interacting treatment. A clinician may also consider whether the patient can safely tolerate the exertion associated with sex. Online prescribing should not bypass this cardiovascular assessment.
Non-drug management may support both heart and sexual health. Smoking cessation, treatment of sleep apnea, diabetes management, a Mediterranean-style dietary pattern, weight management when appropriate, and treatment of depression can address shared contributors. Couples counseling or sex therapy may be valuable when fear, communication, or performance anxiety persists.
Cardiac Rehabilitation and Recovery of Sexual Function
Cardiac rehabilitation combines supervised exercise, risk-factor management, education, and behavioral support. Its main purpose is to improve cardiovascular outcomes and functional capacity, not to serve as an ED treatment. However, improved exercise tolerance, endothelial function, confidence, and symptom control may also support sexual recovery.
In a 2024 systematic review and meta-analysis, Sadeghi and colleagues evaluated cardiac rehabilitation and erectile function in men with cardiovascular disease. Across six studies, rehabilitation was associated with a statistically significant but modest improvement in erectile function.[5] The authors cautioned that the evidence base was limited by small samples and differences in rehabilitation protocols and patient populations.
This distinction matters. A modest average benefit means some men may experience meaningful improvement, while others will not. Rehabilitation cannot reverse every cause of ED, particularly advanced neuropathy, severe penile vascular disease, medication interactions, or major hormonal abnormalities. Still, it offers a clinically coherent way to improve the cardiovascular reserve needed for daily activity and intimacy.
Men enrolled in rehabilitation can ask their care team directly about sexual activity. Questions may include what level of exertion is safe, how to respond to symptoms during sex, whether cardiac medicines could be adjusted, and whether ED treatment is compatible with the current regimen. These conversations are routine medical care, not an optional lifestyle concern.
Conclusion
Heart failure and erectile dysfunction are linked through endothelial dysfunction, reduced circulation, limited exercise capacity, shared cardiometabolic disease, medication effects, and psychological stress. Recent reviews suggest sexual problems are common, but an individual evaluation remains essential because heart-failure severity, nitrate use, blood pressure, and comorbid illness materially change what treatment is safe. Men should not stop heart medication on their own, and persistent ED should be discussed with both cardiovascular and prescribing clinicians.
For broader evidence-based reading, visit the men's health blog. If you're exploring clinically-formulated options, OnyxMD offers physician-supervised treatment plans, including EPIQ CHEWS, starting with a free online assessment at questionnaire.getonyxmd.com. Eligibility depends on a clinician's review, and nitrate use or unstable cardiovascular disease may make PDE5-inhibitor treatment inappropriate.
These statements have not been evaluated by the FDA. This content is for informational purposes only and does not constitute medical advice.
References
da Silva ML, Costa NL, Jacomo RH, Alves AT, de Melo RA, da Costa Cunha K. The impact of heart failure on the sexual response cycle: A systematic review. Heart & Lung. 2022;56:50-56. doi:10.1016/j.hrtlng.2022.05.013
Carella MC, Forleo C, Stanca A, et al. Heart Failure and Erectile Dysfunction: a Review of the Current Evidence and Clinical Implications. Current Heart Failure Reports. 2023;20(6):530-541. doi:10.1007/s11897-023-00632-y
Akintomide AO, Akinlade OM, Ajayi AE, et al. Burden of erectile dysfunction among heart failure patients in a centre in South-Western Nigeria: a pilot study. Annals of Ibadan Postgraduate Medicine. 2022;20(2):103-107. PubMed
Li Q, Long Q, Ren B, Bing S. Causal association between cardiovascular diseases and erectile dysfunction: a two-sample bidirectional Mendelian randomization study. Frontiers in Cardiovascular Medicine. 2023;10:1094330. doi:10.3389/fcvm.2023.1094330
Sadeghi M, Askari A, Bostan F, et al. Impact of cardiac rehabilitation on erectile dysfunction in cardiovascular patients: a systematic review and meta-analysis. Sexual Medicine. 2024;12(3):qfae043. doi:10.1093/sexmed/qfae043
Medical Disclaimer: The information provided on this website is for educational and informational purposes only and is not intended as medical advice. OnyxMD services should not be used to diagnose, treat, cure, or prevent any disease or medical condition. Always consult with a qualified healthcare provider before beginning any supplement regimen or health program.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Individual Results: Results may vary. The experiences and testimonials presented on this website are individual results that may not be typical. Your experience may be different.
Telehealth Services: OnyxMD provides telehealth services in 47 states (excluding AK, MS, NJ) through licensed healthcare providers via our partner Beluga Health, P.A. Services are subject to clinical evaluation and may not be appropriate for all individuals. Prescriptions fulfilled by Strive Pharmacy LLC (License #99-9817) and EPIQ SCRIPTS LLC.